Literature DB >> 17716663

Absence of 4-1BB increases cell influx into the peritoneal cavity in response to LPS stimulation by decreasing macrophage IL-10 levels.

Hyun-Hee Shin1, Ji-Eun Lee, Hye-Seon Choi.   

Abstract

Peritoneal injection of lipopolysaccharide (LPS) increased the influx of polymorphonuclear leukocytes and macrophages into the peritoneal cavity (PEC), with significantly higher cell numbers in the 4-1BB-deficient (KO) mice than in wild-type (WT) mice. The peritoneal macrophages of KO mice contained less IL-10 transcripts and protein than those of WT after LPS treatment, and immobilization of 4-1BB-Fc increased the level of IL-10. Injection of IL-10 resulted in lower cell numbers into the PEC of KO mice, suggesting that lower level of IL-10 is responsible for stimulated cell influx in KO mice due to lack of 4-1BB and 4-1BBL interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716663     DOI: 10.1016/j.febslet.2007.08.015

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Blockade of CD137 signaling counteracts polymicrobial sepsis induced by cecal ligation and puncture.

Authors:  Quang-Tam Nguyen; Seong-A Ju; Sang-Min Park; Sang-Chul Lee; Hideo Yagita; In Hee Lee; Byung-Sam Kim
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

2.  CD137 expressed on neutrophils plays dual roles in antibacterial responses against Gram-positive and Gram-negative bacterial infections.

Authors:  Quang-Tam Nguyen; Thu-Ha T Nguyen; Seong-A Ju; Yea-Sol Lee; Seung Hyun Han; Sang-Chul Lee; Byoung S Kwon; Rina Yu; Gyu Yeol Kim; Byung Ju Lee; Byung-Sam Kim
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

3.  Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells.

Authors:  Seung-Woo Lee; Yunji Park; Takanori So; Byoung S Kwon; Hilde Cheroutre; Robert S Mittler; Michael Croft
Journal:  Nat Immunol       Date:  2008-07-06       Impact factor: 25.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.